A Senate Subcommittee Just Put the COVID Shot Cancer Question on the Record

On Wednesday a U.S. Senate subcommittee gaveled in a hearing on whether the mRNA COVID-19 shots can plausibly cause cancer, and whether the scientists trying to ask that question in the medical literature have been punished for doing so. The Homeland Security Permanent Subcommittee on Investigations titled it “Plausible Mechanisms of COVID-19 Injections Causing Cancer and Attacks on Scientific Publications and Research.” Both halves of that title matter. The mechanism question is the one the public has been told for five years it is not allowed to ask. The publication-attack question is how that prohibition was enforced.

To see why this hearing is unusual, it helps to remember how vaccine science has been governed since the 1986 liability shield. Once a product is shielded from tort exposure and folded into a recommended schedule, the institutions that would normally adjudicate its safety, the journals, the regulators, the medical societies, start sharing an interest in not finding anything. That structural drift is the background against which the testimony on Wednesday has to be read. The witnesses were not announcing a discovery. They were asking the Senate to look at why the discovery process has been jammed.

The witness who drew the most attention was Dr. Aseem Malhotra, the British cardiologist who in January 2021 went on television urging mass vaccination and who now publicly calls for the mRNA products to be withdrawn. He told the subcommittee how he got there, beginning with his own father’s sudden cardiac death months after a second dose and walking through the post-mortem work he did on the published trial data. Malhotra did not come to this question from outside medicine. He came from inside the consensus and changed his mind in public, while paying for it professionally. His testimony foregrounded that arc deliberately, because the credibility of the question turns on who is allowed to ask it.

Across the aisle of the witness table sat Dr. Julie Gralow, chief medical officer of the American Society of Clinical Oncology, who told the subcommittee that there is no clinical evidence proving mRNA COVID vaccines cause cancer. That is a defensible scientific position as stated. It is also a narrower claim than the one the subcommittee took up. The hearing was not whether causation has been proven. It was whether the biological pathway is plausible enough that the post-market surveillance system is obligated to take it seriously. Those are different evidentiary thresholds, and conflating them is itself a tell about how the establishment defense has been argued.

The mechanism case the witnesses laid out rests on findings that have been accumulating in peer-reviewed work since 2023. Witnesses cited biodistribution data showing the lipid nanoparticles carry the mRNA payload well beyond the deltoid. Free spike protein has been detected in the bloodstream of some vaccine recipients in the weeks after dosing, in a study of patients who developed post-vaccine myocarditis. Researchers in Canada, Germany, and the United States have reported residual DNA plasmid fragments in the commercial vials above the regulatory threshold the agencies themselves set. Spike protein interferes with the p53 tumor suppressor pathway in cell-culture work. None of these findings, taken alone, proves a population-level cancer signal. Taken together, they describe a pathway plausible enough that pharmacovigilance is supposed to lean in, not look away.

The second half of the hearing is where it stopped being a science argument and became an institutional one. Dr. Sabine Hazan, the gastroenterologist whose lab work on COVID and the gut microbiome was retracted after publication, described being told the retraction reasons did not match the science. Dr. Jessica Rose and Dr. Peter McCullough, who have publicly documented analogous retraction and deplatforming experiences, represent the same pattern the hearing was built around. Dr. Wafik El-Deiry, the Brown oncologist who chaired one of the panels, described coordinated reputation attacks on PubPeer aimed at researchers who published in the wrong direction. Witnesses pointed to the BMJ Public Health fight over Mostert’s all-cause mortality work as a live example. Each event was reported in its moment as a routine correction. Laid in a row in front of a Senate subcommittee, the witnesses argued, they describe something different: a narrowing, by editors and societies and platforms acting in parallel, of what the literature is permitted to conclude about a single class of products.

This is the part the establishment defense cannot reach by repeating that the mechanism evidence is preliminary. Even if it is preliminary, the question of why it is being prevented from maturing is a separate question, and it is the one the subcommittee built its second clause around. You cannot tell the public the science is settled while also ensuring the science that would unsettle it cannot reach print. That is not consensus. That is the appearance of consensus, produced by editorial intervention rather than by data.

Be honest about what Wednesday did and did not do. The FDA has not changed a label. The CDC schedule is unchanged. Pfizer and Moderna’s post-market surveillance filings continue to report no cancer signal. The legacy outlets that bothered to cover the hearing covered it almost entirely as a stunt. What moved is narrower and more important: a question that for five years was confined to substacks and rumble shows is now in the congressional record, asked by witnesses with hospital appointments and peer-reviewed citations, under oath.

What to watch next is whether the record built on Wednesday gets used. Three concrete tells: whether HHS releases the underlying v-safe and VAERS files in a form independent researchers can actually query, rather than the aggregated views the CDC has historically been willing to share; whether any of the retracted mechanism papers get a serious second look once the publication-attack testimony is part of a congressional record that journals have to answer to; and whether the reconstituted FDA vaccine advisory committee takes up the plausible-mechanism question on its own agenda, rather than waiting for a captured journal to declare it closed. Dr. John Campbell, the British nursing educator whose pandemic explainers built one of the most-watched independent medical channels online, walked his audience through the testimony in a Friday video that treats the hearing as the inflection point it is. He is probably right about that. Regulatory failures usually do not get unwound by a single piece of evidence. They get unwound when the room in which the evidence is allowed to be discussed finally gets reopened. On Wednesday, that room was the United States Senate.

A Senate Subcommittee Just Put the COVID Shot Cancer Question on the Record

Sources

Marcus Chen

A Senate Subcommittee Just Put the COVID Shot Cancer Question on the Record

Sources

Marcus Chen

Stories like this, every Sunday.

More to read

A 16-Foot Fire Tornado Burned an Oil Slick With 40% Less Soot. Cleanup Crews Have Been Breathing the Same Old Smoke Since the Exxon Valdez.

The $401 CBC and the $32 CBC Are the Same Test

The Hernia FAQ That Forgets to Mention the Implant